AN2 Therapeutics’ $69 Million Initial Public Offering

Laura Testa North America Legal Chronicle
Tagged:

Cooley advised AN2 Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering.AN2 Therapeutics, Inc. announced its upsized initial public offering of 4,600,000…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here